143 related articles for article (PubMed ID: 19650060)
1. Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study.
Tsui NB; Wong BC; Leung TY; Lau TK; Chiu RW; Lo YM
Prenat Diagn; 2009 Nov; 29(11):1031-7. PubMed ID: 19650060
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.
Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955
[TBL] [Abstract][Full Text] [Related]
3. C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma.
Go AT; Visser A; Mulders MA; Twisk JW; Blankenstein MA; van Vugt JM; Oudejans CB
Prenat Diagn; 2007 Feb; 27(2):146-9. PubMed ID: 17186567
[TBL] [Abstract][Full Text] [Related]
4. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21.
Tsui NB; Akolekar R; Chiu RW; Chow KC; Leung TY; Lau TK; Nicolaides KH; Lo YM
Clin Chem; 2010 Jan; 56(1):73-81. PubMed ID: 19892844
[TBL] [Abstract][Full Text] [Related]
5. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
Avent ND; Madgett TE; Maddocks DG; Soothill PW
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):175-9. PubMed ID: 19262379
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21.
Jorgez CJ; Dang DD; Wapner R; Farina A; Simpson JL; Bischoff FZ
Hum Reprod; 2007 Aug; 22(8):2267-72. PubMed ID: 17584747
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.
Lau TK; Chen F; Pan X; Pooh RK; Jiang F; Li Y; Jiang H; Li X; Chen S; Zhang X
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1370-4. PubMed ID: 22070770
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
9. Digital PCR for the molecular detection of fetal chromosomal aneuploidy.
Lo YM; Lun FM; Chan KC; Tsui NB; Chong KC; Lau TK; Leung TY; Zee BC; Cantor CR; Chiu RW
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13116-21. PubMed ID: 17664418
[TBL] [Abstract][Full Text] [Related]
10. [Noninvasive prenatal screen of trisomy-21 using maternal plasma fetal free RNA allelic ratio].
Xu Y; Zhai S; Luo X; Zhang Y; Ran L; Ren L
Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):568-75. PubMed ID: 26675178
[TBL] [Abstract][Full Text] [Related]
11. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
12. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
Ashoor G; Syngelaki A; Wagner M; Birdir C; Nicolaides KH
Am J Obstet Gynecol; 2012 Apr; 206(4):322.e1-5. PubMed ID: 22464073
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
Lo YM
BJOG; 2009 Jan; 116(2):152-7. PubMed ID: 19076946
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.
Bianchi DW; Platt LD; Goldberg JD; Abuhamad AZ; Sehnert AJ; Rava RP;
Obstet Gynecol; 2012 May; 119(5):890-901. PubMed ID: 22362253
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.
Tsui DW; Lam YM; Lee WS; Leung TY; Lau TK; Lau ET; Tang MH; Akolekar R; Nicolaides KH; Chiu RW; Lo YM; Chim SS
PLoS One; 2010 Nov; 5(11):e15069. PubMed ID: 21152411
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
Liao GJ; Chan KC; Jiang P; Sun H; Leung TY; Chiu RW; Lo YM
PLoS One; 2012; 7(5):e38154. PubMed ID: 22666469
[TBL] [Abstract][Full Text] [Related]
17. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
18. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection.
Lo YM; Tsui NB; Chiu RW; Lau TK; Leung TN; Heung MM; Gerovassili A; Jin Y; Nicolaides KH; Cantor CR; Ding C
Nat Med; 2007 Feb; 13(2):218-23. PubMed ID: 17206148
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.
Liang D; Lv W; Wang H; Xu L; Liu J; Li H; Hu L; Peng Y; Wu L
Prenat Diagn; 2013 May; 33(5):409-15. PubMed ID: 23299662
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
